Danfeng Cai
Biographic Data
| ID | 5676445 |
|---|---|
| NAME | Danfeng Cai |
| GIVEN NAMES | Danfeng |
| FAMILY NAME | Cai |
| SIGNATURE | CAI D |
| AFFILIATIONS | Nanjing University of Chinese Medicine |
| ORCID | 0000-0003-1623-5077 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Assessing the roles of subjective value and valence in outcome evaluation for consumer products: Evidence from behavioral and electrophysiological experiments
Liuwei Dihuang prevents postmenopausal atherosclerosis and endothelial cell apoptosis via inhibiting DNMT1-medicated ERα methylation
Liuwei Dihuang soft capsules inhibits the phenotypic conversion of VSMC to prevent the menopausal atherosclerosis by up-regulating the expression of myocardin
Liuwei Dihuang soft capsules attenuates endothelial cell apoptosis to prevent atherosclerosis through GPR30-mediated regulation in ovariectomized ApoE-deficient mice
No prominent works on this page.
Liuwei Dihuang soft capsules attenuates endothelial cell apoptosis to prevent atherosclerosis through GPR30-mediated regulation in ovariectomized ApoE-deficient mice
Liuwei Dihuang prevents postmenopausal atherosclerosis and endothelial cell apoptosis via inhibiting DNMT1-medicated ERα methylation
Liuwei Dihuang soft capsules inhibits the phenotypic conversion of VSMC to prevent the menopausal atherosclerosis by up-regulating the expression of myocardin
Assessing the roles of subjective value and valence in outcome evaluation for consumer products: Evidence from behavioral and electrophysiological experiments
Endocrinology (3 works) · Internal Medicine (3 works) · Medicine (3 works) · Biochemistry (2 works) · Biology (2 works) · Gene expression (2 works) · Pharmacology (2 works) · Apoptosis (1 works) · Atherosclerosis and Cardiovascular Diseases (1 works) · Biological Stains and Phytochemicals (1 works)